Korro Bio, Inc. (KRRO) Net Margin
- 2025-12-31: Net Margin -3873.22%.
- 2025-09-30: Net Margin -1656.97%.
- 2025-06-30: Net Margin -1765.07%.
- 2025-03-31: Net Margin -917.14%.
Complete source-backed net margin history.
- Available history
- 2019-09-30 to 2025-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -3873.22% |
| 2025-09-30 | -1656.97% |
| 2025-06-30 | -1765.07% |
| 2025-03-31 | -917.14% |
| 2024-12-31 | -933.47% |
| 2021-06-30 | -187.49% |
| 2021-03-31 | -438.08% |
| 2020-12-31 | -102.83% |
| 2020-09-30 | -47.49% |
| 2020-06-30 | -70.69% |
| 2020-03-31 | -67.63% |
| 2019-12-31 | -116.65% |
| 2019-09-30 | -2.37% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -1834.48% |
| 2024-12-31 | -3680.36% |
| 2021-12-31 | -601.98% |
| 2020-12-31 | -71.68% |
| 2019-12-31 | -64.76% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |